Results from a multi-center European study of Bolton Medical‘s (Fort Lauderdale, Florida) RELAY Thoracic Stent Graft have recently been published in Journal of Vascular Surgery. The authors conclude that the results “support the safety of thoracic endovascular aortic repair with the RELAY stent graft, even in acute and complicated situations. The device was highly efficient in angulated aortic anatomies, with acceptable mortality and a low rate of neurologic complications.”
Some findings from the study:
A extremely low stroke rate (1,6%) within the whole population, despite the proximal landing zone was in the aortic arch in 79% of cases, enrollment of high risk patients, acute situations and difficult anatomies A low endoleak rate (4,6%) of any type No intra-operative conversion to open procedures In 80% of cases, only 1 stent-graft was required for complete treatment, thus minimizing risk of disconnection, time of intervention, fluoroscopic load and cost. 30-Day mortality (7,2%) and survival rate at 12 months (97,3%) and 24 months (95,9%)
Press release: RELAY Thoracic Stent-Graft shows safety and efficacy in the
endovascular treatment of a broad "real life" range of Thoracic Aortic Diseases…
Product page: RELAY Thoracic Stent Graft…
Abstract in Journal of Vascular Surgery: Final operative and midterm results of the European experience in the RELAY Endovascular Registry for Thoracic Disease (RESTORE) study